C31.0 ICD-10-CM Code: Malignant neoplasm of maxillary sinus
C31.0 maps to CMS-HCC V28 21 (RAF 0.671). Documentation must support MEAT. MEAT criteria · RAF calculator · HCC Buddy coding tools
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of respiratory and intrathoracic organs (C30-C39)
C31.0
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceMalignant neoplasm of maxillary sinus
Cancer that develops in the maxillary sinus, the large air-filled cavity in the cheekbone above the teeth.

Buddy Insight
Maxillary sinus cancer is the most common paranasal sinus malignancy, often presenting at advanced stages because early symptoms mimic sinusitis.
CMS-HCC V28
MappedHCC 21
RAF 0.671
CMS-HCC V24
MappedHCC 11
RAF 0.307
ACA/HHS
MappedHCC 11
Varies by metal level
ESRD/PACE
MappedHCC 11
RAF 0.059
RXHCC
MappedHCC 22
RAF 0.124
Code Book Path
Inclusion Terms
Official- Malignant neoplasm of antrum (Highmore) (maxillary)
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for C31.0 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for C31.0 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for C31.0 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for C31.0 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for C31.0 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for C31.0 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is C31.0 an HCC code?
Yes. C31.0 (Malignant neoplasm of maxillary sinus) maps to Lymphoma and Other Cancers under the CMS-HCC V28 risk adjustment model (and Colorectal, Bladder, and Other Cancers under V24), with a community non-dual aged RAF of 0.671. It is billable for payment year 2026.
Coder answer: C31.0 is billable and maps to V28 HCC 21, Lymphoma and Other Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.
- Code
- C31.0
- Description
- Malignant neoplasm of maxillary sinus
- HCC (V28)
- HCC 21 — Lymphoma and Other Cancers
- RAF
- 0.671
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
Each model's RAF is its CMS base weight for that model's standard population, so weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
Work C31.0 in the Code Book — tabular path, V28 RAF, and MEAT checklist →
MEAT Criteria for C31.0
For C31.0 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C31.0 during that encounter, not just copy-forwarded from a problem list.
Coder workflow notes
Get the V28 RAF + MEAT cheat sheet
One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
C31.0 is the ICD-10-CM diagnosis code for malignant neoplasm of maxillary sinus. Cancer that develops in the maxillary sinus, the large air-filled cavity in the cheekbone above the teeth. C31.0 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of respiratory and intrathoracic organs (c30-c39).
Under the CMS-HCC V28 risk adjustment model, C31.0 maps to Lymphoma and Other Cancers (HCC 21) with a community, non-dual, aged base RAF weight of 0.671. Under the older CMS-HCC V24 model, C31.0 maps to Colorectal, Bladder, and Other Cancers (HCC 11) with a community, non-dual, aged base RAF weight of 0.307. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Maxillary sinus cancer often presents late; document extent of invasion into adjacent structures. Because C31.0 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C31.0 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Maxillary sinus cancer often presents late; document extent of invasion into adjacent structures
- •Distinguish from other paranasal sinus cancers and ensure correct sinus site is coded
Clinical Significance
Maxillary sinus cancer is the most common paranasal sinus malignancy, often presenting at advanced stages because early symptoms mimic sinusitis. Treatment typically requires radical surgery (maxillectomy) with adjuvant radiation, resulting in high healthcare resource utilization. Accurate coding supports appropriate risk adjustment for these complex patients.
Documentation Requirements
- ✓Pathology confirmation with histological type (squamous cell most common, adenoid cystic, mucosal melanoma)
- ✓Imaging documenting extent of disease and invasion of adjacent structures (orbit, palate, infratemporal fossa)
- ✓TNM staging specific to maxillary sinus (Ohngren line relevant for prognosis)
- ✓Treatment plan including surgical approach and radiation therapy
- ✓Clear documentation distinguishing maxillary sinus from other paranasal sinuses
Commonly Confused Codes
- •C31.1: Ethmoidal sinus cancer: Adjacent sinus; ensure documentation specifies the maxillary sinus
- •C30.0: Nasal cavity cancer: Maxillary sinus tumors may extend into the nasal cavity: code the primary site
- •C03.0-C03.1: Malignant neoplasm of upper gum: Floor of maxillary sinus is the palate; oral cavity cancers are coded differently
- •J32.0: Chronic maxillary sinusitis: Chronic sinusitis symptoms can mask underlying malignancy

